Pfizer Pipeline
Pfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of January 31, 2017 Included are 62 NMEs, 26 additional indications, plus 8 biosimilars
Download Pfizer Pipeline
Information
Domain:
Source:
Link to this page:
Documents from same domain
NARDIL - Pfizer
www.pfizer.com1 NARDIL® (Phenelzine Sulfate Tablets, USP) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 5. fire fighting measures
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 7. handling and storage
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.comMATERIAL SAFETY DATA SHEET _____ Measures for Cleaning / Collecting: Contain the source of spill if it is safe to do so.
PFIZER FACTS The Burden of Cancer in Asia
www.pfizer.comTheburdenofcancerinAsia I n2002,4.2millionnewcancercases—39%ofnewcasesworldwide—werediagnosedamong …
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 2. hazards identification
USPI medroxyprogesterone acetate - Depo …
www.pfizer.com1 Depo-Provera® medroxyprogesterone acetate injectable suspension, USP DESCRIPTION DEPO-PROVERA Sterile Aqueous Suspension contains medroxyprogesterone acetate,
Patient Information About - Pfizer
www.pfizer.comPatient Information About depo-subQ provera 104™ medroxyprogesterone acetate injectable suspension 104 mg/0.65 mL WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD
Pfizer Inc 100 Route 206 North Peapack, NJ 07977 …
www.pfizer.comApril 13, 2015 Pfizer Inc 100 Route 206 North Peapack, NJ 07977 Email: pfizerinjectables@pfizer.com Global Established Pharmaceuticals Depo®-Testosterone (testosterone cypionate injection, USP) CIII
2. HAZARDS IDENTIFICATION - Pfizer
www.pfizer.com1. PRODUCT AND COMPANY IDENTIFICATION Product Name Chapstick Products Common Name Not applicable Chemical Name Not applicable Synonyms ChapStick Classic, ChapStick Lip Moisturizer, ChapStick Medicated, ChapStick Flava-Craze,
Related documents
WHO Drug Information
apps.who.int152 WHO Drug Information Vol. 31, No. 2, 2017 Publications and events 193 Access to medical products Fair Pricing Forum; Information guide on biosimilars;WHO to pilot prequalification of
TRENDS IN Biologic Medicine - Biotechnology by …
www.amgenbiotech.com3 As with any new category, science must lead the U.S. introduction of biosimilars. In the U.S. healthcare landscape, experts in therapeutic areas who …
An Analysis of the US Biosimilars Development …
www.biopharma.comSupplement Ju n e 2013 11(6) s BioProcess International 19 European Medicines Agency grants 10 years of such protection). BII estimated US and EU …
The U.S. Biosimilars Market
www.dean.com22 The U.S. Biosimilars Market product pharmaceutically. Given the complex nature of protein products and the manufacturing processes that produce them, it is no wonder that debate exists about
Biosimilars in the EU
www.ema.europa.euInformation guide for healthcare professionals Biosimilars in the EU Prepared jointly by the European Medicines Agency and the European Commission
Guideline on similar biological medicinal ... - …
www.ema.europa.eu30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union www.ema.europa.eu/contact Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555
Chapter 1 The era of biological medicines - IGBA
www.igbamedicines.orgA biological medicine is a mixture of closely related variants of the same protein. 1. References: 1. EC/EMA. Biosimilars in the EU – Information guide for Healthcare Professionals 2017. Available at: h
Chapter 5 The benefits of biosimilar medicines - IGBA
www.igbamedicines.orgThe benefits of biosimilar medicines . Biosimilar medicines have demonstrated similarity with reference biologicals in terms of structure, function,